L. S. D. Dal Col

Randomized clinical trial of BCG vaccine in patients with convalescent COVID‐19: Clinical evolution, adverse events, and humoral immune response

Q. Trinh, L. Reis, M. Bajgelman, 2022, Journal of internal medicine.

PSA nadir predicts biochemical recurrence after external beam radiation therapy combined to high dose rate brachytherapy in the treatment of prostate cancer.

C. Monti, Diego M. Capibaribe, Leonardo O. Reis, 2022, American journal of clinical and experimental urology.

Presence and predominance of histological grade 3 define cT1HG bladder cancer prognostic groups

L. Reis, A. Billis, F. Denardi, 2021, Investigative and clinical urology.

Time Analysis of an Emergent Infection Spread Among Healthcare Workers: Lessons Learned from Early Wave of SARS-CoV-2

M. Jalalizadeh, Keini Buosi, F. A. Dionato, 2022, International journal of general medicine.

Time-analysis of COVID-19 dispersion among health care workers and the general population

L. Reis, C. Giacomelli, K. Ferrari, 2021, medRxiv.

Comparing Bacillus Calmette-Guérin (BCG) strains in convalescent COVID-19 patients.

A. P. Domingues-Junior, M. Jalalizadeh, Keini Buosi, 2023, Immunotherapy.

BCG vaccine safety in COVID-19 convalescent adults: BATTLE a randomized controlled trial

P. Moriel, M. Jalalizadeh, Keini Buosi, 2022, Vaccine.